• Je něco špatně v tomto záznamu ?

Predicting the development of hemophilic arthropathy in patients with hemophilia based on patient age: a retrospective single-center database study

R. Kubeš, M. Stollin, Š. Magersky, M. Bobelyak, J. Vaculík, J. Včelák, A. Antonín Kuběna, J. Loužil, P. Salaj

. 2023 ; 16 (12) : 1099-1105. [pub] 20231218

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24001289

BACKGROUND: Patients with hemophilia (PWH) develop hemophilic arthropathy of the major joints due to recurrent hemarthrosis. This study retrospectively estimated the age at which PWH may expect to develop hemophilic arthropathy and undergo joint replacement surgery. RESEARCH DESIGN AND METHODS: Using retrospective data from PWH at a Czech orthopedic center, Kaplan Meier analyses were used to estimate the cumulative proportions of patients with hemophilic arthropathy and undergoing joint replacement surgery as a function of age. RESULTS: Based on 1028 joint examinations in 167 PWH, hemophilic arthropathy of the knees, elbows, ankles and hips was estimated to develop by a median age of 48, 51, 52 and 61 years, respectively, with ≈80% of patients having such damage by ≈70 years of age. Hemophilic arthropathy of the shoulder occurred much later (median >80 years). In patients undergoing knee or hip replacement surgery, hemophilic arthropathy of the knee and hip occurred at a median age of ≈50 and ≈60 years, respectively, with replacement surgery occurring at a median of ≈70 and >75 years. CONCLUSIONS: In PWH, the risk of developing hemophilic arthropathy accumulates continuously over the patient's lifetime, allowing predictions about the ages at which such damage and joint replacement surgery may occur.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24001289
003      
CZ-PrNML
005      
20241014101517.0
007      
ta
008      
240109s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/17474086.2023.2289536 $2 doi
035    __
$a (PubMed)38015035
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kubeš, Radovan $u Department of Orthopaedics, First Faculty of Medicine, Charles University, Prague 8, Czech Republic $u Orthopedic Clinic, First Faculty of Medicine Charles University and Institute for Postgraduate Education in Medicine, Prague 8, Czech Republic
245    10
$a Predicting the development of hemophilic arthropathy in patients with hemophilia based on patient age: a retrospective single-center database study / $c R. Kubeš, M. Stollin, Š. Magersky, M. Bobelyak, J. Vaculík, J. Včelák, A. Antonín Kuběna, J. Loužil, P. Salaj
520    9_
$a BACKGROUND: Patients with hemophilia (PWH) develop hemophilic arthropathy of the major joints due to recurrent hemarthrosis. This study retrospectively estimated the age at which PWH may expect to develop hemophilic arthropathy and undergo joint replacement surgery. RESEARCH DESIGN AND METHODS: Using retrospective data from PWH at a Czech orthopedic center, Kaplan Meier analyses were used to estimate the cumulative proportions of patients with hemophilic arthropathy and undergoing joint replacement surgery as a function of age. RESULTS: Based on 1028 joint examinations in 167 PWH, hemophilic arthropathy of the knees, elbows, ankles and hips was estimated to develop by a median age of 48, 51, 52 and 61 years, respectively, with ≈80% of patients having such damage by ≈70 years of age. Hemophilic arthropathy of the shoulder occurred much later (median >80 years). In patients undergoing knee or hip replacement surgery, hemophilic arthropathy of the knee and hip occurred at a median age of ≈50 and ≈60 years, respectively, with replacement surgery occurring at a median of ≈70 and >75 years. CONCLUSIONS: In PWH, the risk of developing hemophilic arthropathy accumulates continuously over the patient's lifetime, allowing predictions about the ages at which such damage and joint replacement surgery may occur.
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    12
$a hemofilie A $x komplikace $7 D006467
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a hemartróza $x diagnóza $x etiologie $7 D006395
650    _2
$a kolenní kloub $7 D007719
650    12
$a loketní kloub $7 D004551
655    _2
$a časopisecké články $7 D016428
700    1_
$a Stollin, Martin $u Department of Orthopaedics, First Faculty of Medicine, Charles University, Prague 8, Czech Republic $u Orthopedic Clinic, First Faculty of Medicine Charles University and Institute for Postgraduate Education in Medicine, Prague 8, Czech Republic
700    1_
$a Magersky, Štěpán $u Department of Orthopaedics, First Faculty of Medicine, Charles University, Prague 8, Czech Republic $u Orthopedic Clinic, First Faculty of Medicine Charles University and Institute for Postgraduate Education in Medicine, Prague 8, Czech Republic
700    1_
$a Bobelyak, Maryan $u Department of Orthopaedics, First Faculty of Medicine, Charles University, Prague 8, Czech Republic $u Orthopedic Clinic, First Faculty of Medicine Charles University and Institute for Postgraduate Education in Medicine, Prague 8, Czech Republic
700    1_
$a Vaculík, Jan $u Department of Orthopaedics, First Faculty of Medicine, Charles University, Prague 8, Czech Republic $u Orthopedic Clinic, First Faculty of Medicine Charles University and Institute for Postgraduate Education in Medicine, Prague 8, Czech Republic
700    1_
$a Včelák, Josef $u Department of Orthopaedics, First Faculty of Medicine, Charles University, Prague 8, Czech Republic $u Orthopedic Clinic, First Faculty of Medicine Charles University and Institute for Postgraduate Education in Medicine, Prague 8, Czech Republic
700    1_
$a Antonín Kuběna, Aleš $u Department of Social and Clinical Pharmacy, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
700    1_
$a Loužil, Jan, $u Transfusiological Division, Institute of Hematology and Blood Transfusion, Prague 2, Czech Republic $d 1980- $7 xx0324132
700    1_
$a Salaj, Peter $u Centre for Thrombosis and Hemostasis, Institute of Hematology and Blood Transfusion, Prague 2, Czech Republic
773    0_
$w MED00174419 $t Expert review of hematology $x 1747-4094 $g Roč. 16, č. 12 (2023), s. 1099-1105
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38015035 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20241014101515 $b ABA008
999    __
$a ok $b bmc $g 2049736 $s 1210983
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 16 $c 12 $d 1099-1105 $e 20231218 $i 1747-4094 $m Expert review of hematology $n Expert Rev Hematol $x MED00174419
LZP    __
$a Pubmed-20240109

Najít záznam

Citační ukazatele

Možnosti archivace